• No results found

Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study

N/A
N/A
Protected

Academic year: 2021

Share "Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER Cohort Study"

Copied!
11
0
0

Loading.... (view fulltext now)

Full text

References

Related documents

To evaluate the effectiveness of three wound manage- ment approaches (standard care silver dressings (Acti- coat® and Mepitel® or Mepilex Ag®)) or an autologous skin cell

Consistent with current research and recommenda- tions, key components in effective health professional communications with patients will (a) deliver simple, direct, and relevant

After normalization for lung size, changes in lung dimensions between inspiration and expiration were used for analysis; normalization was based on the cranial-caudal length

NK: neurokinin; SP: substance P; FcεRI: high affinity IgE receptor; MRGPRX2: Mas-related G-protein-coupled receptor expressed on human mast cells; TNF: tumor necrosis factor;

Patients with RH were more likely to be men, and to have higher waist circumference, increased blood levels of HbA1c, triglycerides, and serum creatinine, lower blood levels of

In the context of increased international acknowledge- ment that the humanitarian landscape needs to include local actors driving responses to crises, the health response

The prevalence of anxiety, somatization disorder, alcohol abuse and eating disorders was greater in Guasca than Guatavita with a prevalence of 32.5% and 25.7% for an- xiety, 73.8%

Recombinant factor VIIa (rFVIIa), originally developed for the treatment of acquired inhibitors associated with hemophilia [1,2], has been successfully used for bleeding due to